Limited Review of Aciphex.

Short- and Long-term Essence of a Long-acting Somatostatin Analogue, Lanreotide (SR-L), on Metastatic Gastrinoma Gaztambide S, Vazquez JA. J Endocrinol Invest. 1999;22(2):144-146.
Medical communication is the elective therapy for patients with gastrinoma when the tumor is not found at operating room or is unresectable or when there is a metastatic disease.
H2-blockers and omeprazole are able to ascendence gastric acid biological process and, in component, somatostatin analogues alteration gastrin levels.
A new long-acting and slow handout preparation of a somatostatin analogue (lanreotide, SR-L) has been developed.
We treated two patients agony from gastrinoma, totality gastrectomy and hepatic metastases with 30 mg intramuscular injections of SR-L every 15 and 10 days, respectively, for a seven-month section.
After the intervention, gastrin levels decreased from 35,494 and 15,086 ng/l to 3,211 and 167 ng/l (92 and 98% below pre-treatment levels) in case 1 and 2 respectively, with a reduction of symptoms and no side effects.

of its Use in Acid-Related Gastrointestinal Disorders Langtry HD, Markham A. Drugs. 1999;58(4):725-742.
Aciphex is an inhibitor of the gastric proton pump.
It causes dose-dependent restraint of acid secernment and has a more rapid start of legal action than omeprazole.
Duodenal ulcers healed faster after attention with Aciphex 20 or 40 mg/day than medicament or ranitidine 150 mg 4 rhythmicity daily and at a generally similar rate to omeprazole 20 mg/day in patients with duodenal ulcers; rabeprazole was similar or fighter to these agents in relieving symptoms.
This is a part of article Limited Review of Aciphex. Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog